Table 3.

Patients’ medication at the beginning of the study

Medication at beginning of the study	CLBP (n = 19)	NeP (n = 19)
Ibuprofen (no. (%))	3 (16)	2 (11)
Diclofenac (no. (%))	2 (11)	3 (16)
Paracetamol (no. (%))	3 (16)	2 (11)
Metamizole (no. (%))	1 (5)	1 (5)
Opioids (no. (%))	2 (11)	3 (16)
Pregabalin (no. (%))	0 (0)	1 (5)
Duloxetine (no. (%))	0 (0)	1 (5)

There is no significant difference in the intake of analgesics or coanalgesics in patients with CLBP and NeP. Data are presented as mean ± SD, n = 19, statistical testing was performed using Fisher’s exact test

CLBP chronic low back pain; NeP neuropathic pain (symmetrical polyneuropathy, peripheral mononeuropathy, postherpetic neuralgia, orofacial pain)